Analysis – Page 2 – Goldea Capital

Norwood Financial Corp Announces Timing of Fourth Quarter 2025 Earnings Release and Conference Call

Written by Customer Service on January 12, 2026. Posted in Public Companies.

HONESDALE, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) — Norwood Financial Corp (Nasdaq Global Market-NWFL) and its subsidiary, Wayne Bank, will release its fourth quarter 2025 financial results before market opens on Thursday, January 22, 2026. On the same day, the Company will host a webcast and conference call at 9:00 a.m. ET to discuss the financial results. To participate in the live call, you may register and connect via webcast using this link: https://register-conf.media-server.com/register/BId8cb7a4a39794e3d8ff337212d6f4fac. Upon registering, dial-in info and a unique pin to join the call will be provided, as well as an email confirmation with details. A slide presentation will simultaneously be available for download on the Investor Relations website at ir.wayne.bank. A replay of the event, as well as a transcript, can be accessed...

Kraig Biocraft Laboratories Takes Possession of Third Rearing Center, Completing Core Infrastructure Upgrades for 2026 Production Scale-Up

Written by Customer Service on January 12, 2026. Posted in Public Companies.

ANN ARBOR, Mich., Jan. 12, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that it has taken possession of its third silkworm rearing center, completing the core physical infrastructure upgrades, underpinning the Company’s massive recombinant spider silk production scale-up planned for 2026. This newest facility represents the final major component of the Company’s multi-year production expansion strategy. With three fully operational rearing centers, Kraig Labs will be able to run three simultaneous production cycles, providing both production diversity and the capacity required to meet and exceed one metric ton of finished spider silk per month. This...

WTW Radar integrates with Databricks to simplify and fast-track data sharing

Written by Customer Service on January 12, 2026. Posted in Public Companies.

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW) today announced the launch of the Radar Connector for Databricks, a significant addition to WTW’s market-leading end-to-end insurance analytics and pricing platform. The new integration allows Radar users to connect securely with Databricks – eliminating manual data movement, accelerating analysis and improving governance. The integration between WTW Radar and Databricks enables Radar to access data by selecting Databricks as a data source and to retrieve data straight from the Databricks Data Intelligence Platform in a single step. After completing their analysis, users can directly transfer results back into Databricks. These activities can also be completed as part of automated processes. The Radar Connector for Databricks offers a faster, smoother and more efficient...

Dimensional Fund Advisors Ltd. : Form 8.3 – RIO TINTO PLC-SPON ADR – Ordinary Shares

Written by Customer Service on January 12, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION (a) Full name of discloser: Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Rio...

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Written by Customer Service on January 12, 2026. Posted in Dividend Reports And Estimates.

ROCKVILLE, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today provided a preliminary update on financial results for the fourth quarter and full year ended December 31, 2025. Preliminary Unaudited Fourth Quarter and Full Year 2025 ResultsCore revenue in the fourth quarter is expected to be between $6.6 million and $6.7 million. Core revenue for the full year is expected to be between $29.5 million and $29.6 million. Strategic Platform License (SPL) program-related revenue in the fourth quarter is expected to be between $0.4 million and $0.6 million. SPL program-related revenue for the full year is expected to be...

CompoSecure Completes Business Combination with Husky Technologies and Rebrands Corporate Entity to GPGI, Inc.

Written by Customer Service on January 12, 2026. Posted in Mergers And Acquisitions.

Completed business combination with Husky Technologies creating a $7.4 billion best-in-class, diversified compounder Rebrands corporate entity to GPGI, Inc. (“Great Positions in Good Industries”) with two reporting segments CompoSecure and HuskyCompleted Business Combination SOMERSET, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) — CompoSecure, Inc. (NYSE: CMPO) completed its previously announced business combination with Husky Technologies Limited (“Husky”), a leader in highly engineered equipment and aftermarket services. The combination of Husky and CompoSecure creates a best-in-class, diversified compounder featuring two global market leaders with ~70% recurring revenues, high margins, and strong free cash flow generation. As previously disclosed, the combined business is valued at $7.4 billion1, representing ~11.6x 2026E Pro Forma...

Dimensional Fund Advisors Ltd. : Form 8.3 – RIO TINTO LTD – Ordinary Shares

Written by Customer Service on January 12, 2026. Posted in Mergers And Acquisitions.

Schouw & Co. share buy-back programme, week 1+2 2026

Written by Customer Service on January 12, 2026. Posted in Mergers And Acquisitions.

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price DKK AmountDKK Friday, 2 January 2026 1,500 661.65 992,470 Monday, 5 January 2026 3,000 665.00 1,995,000 Tuesday, 6 January 2026 1,500 669.00 1,003,500 Wednesday, 7 January 2026 3,000 675.00 2,025,000 Thursday, 8 January 2026 3,000 675.00 2,025,000 Friday,...

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

Written by Customer Service on January 12, 2026. Posted in Earnings Releases And Operating Results.

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences IRVINE, CA – January 12, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leading precision diagnostics company, today reported preliminary fourth quarter and full year 2025 revenues and issued 2026 revenue guidance. The Company expects to report fourth quarter and full year 2025 revenues of approximately $30.5 million and $109 million, respectively, representing year-over-year growth of 23% and 21%, respectively. During the fourth quarter, the Company billed 11,201 tissue-based units and 27,486 liquid-based units, representing year-over-year growth of (5%) and 128%, respectively, reflecting Q4 focus on integration of the Exosome...

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

Written by Customer Service on January 12, 2026. Posted in Public Companies.

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance 36% to 38% Annual YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System Sales and Growth in Number of U.S. Focal One Procedures 69% Annual YoY Growth in Focal One System Placements 28% Q4 YoY Growth in U.S. Procedures Highlights Accelerating Quarterly Procedure Growth AUSTIN, Texas, January 12, 2026 — EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced select preliminary unaudited financial and operational results highlighting record fourth quarter and full-year 2025 HIFU revenue, driven by strong system placements and accelerating procedure growth. The Company also issued initial worldwide revenue guidance for 2026. For the...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals